These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 34368897)
1. Radiomics-based MRI for predicting Erythropoietin-producing hepatocellular receptor A2 expression and tumor grade in brain diffuse gliomas. Liu X; Li J; Liao X; Luo Z; Xu Q; Pan H; Zhou Q; Tao Y; Shi F; Lu G; Zhang Z Neuroradiology; 2022 Feb; 64(2):323-331. PubMed ID: 34368897 [TBL] [Abstract][Full Text] [Related]
2. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study. Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592 [TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence. Zhang J; Wu Y; Wang Y; Zhang X; Lei Y; Zhu G; Mao C; Zhang L; Ma L Eur Radiol; 2023 May; 33(5):3332-3342. PubMed ID: 36576544 [TBL] [Abstract][Full Text] [Related]
4. Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors. Park YW; Choi YS; Ahn SS; Chang JH; Kim SH; Lee SK Korean J Radiol; 2019 Sep; 20(9):1381-1389. PubMed ID: 31464116 [TBL] [Abstract][Full Text] [Related]
5. Predicting histological grade in pediatric glioma using multiparametric radiomics and conventional MRI features. Zhou T; Qiao B; Peng B; Liu Y; Gong Z; Kang M; He Y; Pang C; Dai Y; Sheng M Sci Rep; 2024 Jun; 14(1):13683. PubMed ID: 38871755 [TBL] [Abstract][Full Text] [Related]
6. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas. Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598 [TBL] [Abstract][Full Text] [Related]
7. Model incorporating multiple diffusion MRI features: development and validation of a radiomics-based model to predict adult-type diffuse gliomas grade. Wang P; Xie S; Wu Q; Weng L; Hao Z; Yuan P; Zhang C; Gao W; Wang S; Zhang H; Song Y; He J; Gao Y Eur Radiol; 2023 Dec; 33(12):8809-8820. PubMed ID: 37439936 [TBL] [Abstract][Full Text] [Related]
8. Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging. Hashido T; Saito S; Ishida T J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):606-613. PubMed ID: 34270479 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas. Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822 [TBL] [Abstract][Full Text] [Related]
10. Radiomics strategy for glioma grading using texture features from multiparametric MRI. Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085 [TBL] [Abstract][Full Text] [Related]
11. Radiomics based on multicontrast MRI can precisely differentiate among glioma subtypes and predict tumour-proliferative behaviour. Su C; Jiang J; Zhang S; Shi J; Xu K; Shen N; Zhang J; Li L; Zhao L; Zhang J; Qin Y; Liu Y; Zhu W Eur Radiol; 2019 Apr; 29(4):1986-1996. PubMed ID: 30315419 [TBL] [Abstract][Full Text] [Related]
12. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas. Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813 [TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status. Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065 [TBL] [Abstract][Full Text] [Related]
14. A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas. Wang J; Hu Y; Zhou X; Bao S; Chen Y; Ge M; Jia Z Eur J Radiol; 2022 Feb; 147():110141. PubMed ID: 34995947 [TBL] [Abstract][Full Text] [Related]
15. Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas. Park CJ; Kim S; Han K; Ahn SS; Kim D; Park YW; Chang JH; Kim SH; Lee SK Yonsei Med J; 2024 May; 65(5):283-292. PubMed ID: 38653567 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults. Lv K; Chen H; Cao X; Du P; Chen J; Liu X; Zhu L; Geng D; Zhang J J Neurosurg; 2023 Aug; 139(2):393-401. PubMed ID: 36681946 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion. Chen Y; Xia Y; Tolat PP; Long L; Jiang Z; Huang Z; Tang Q AJR Am J Roentgenol; 2021 Jun; 216(6):1510-1520. PubMed ID: 33826360 [No Abstract] [Full Text] [Related]
18. Molecular subtyping of diffuse gliomas using magnetic resonance imaging: comparison and correlation between radiomics and deep learning. Li Y; Wei D; Liu X; Fan X; Wang K; Li S; Zhang Z; Ma K; Qian T; Jiang T; Zheng Y; Wang Y Eur Radiol; 2022 Feb; 32(2):747-758. PubMed ID: 34417848 [TBL] [Abstract][Full Text] [Related]
20. Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain. Su X; Chen N; Sun H; Liu Y; Yang X; Wang W; Zhang S; Tan Q; Su J; Gong Q; Yue Q Neuro Oncol; 2020 Mar; 22(3):393-401. PubMed ID: 31563963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]